{"id":"W1615542701","doi":"10.1111/j.1464-5491.2012.03624.x","title":"A randomized non‐inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with Type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptin","year":2012,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Novo Nordisk; World Health Organization; Eli Lilly and Company","keywords":"Exenatide; Sitagliptin; Medicine; Metformin; Type 2 diabetes; Internal medicine; Placebo; Postprandial; Nausea; Endocrinology; Gastroenterology; Diabetes mellitus; Insulin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002561403,0.0006237069,0.002234775,0.0005900523,0.0001536823,0.00004135689,0.0002868695,0.00009114649,0.0001487252],"category_scores_gemma":[0.002360224,0.0003605468,0.00008523417,0.0008800981,0.0001511724,0.000310324,0.0001983357,0.0003777905,0.00002810675],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002672003,"about_ca_system_score_gemma":0.00005430755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008608741,"about_ca_topic_score_gemma":0.0002829065,"domain_scores_codex":[0.9957249,0.0004446935,0.001184624,0.0006760036,0.001072966,0.0008968099],"domain_scores_gemma":[0.9957477,0.002269449,0.0004584254,0.0007351768,0.0002659854,0.000523306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07287597,0.002366368,0.8531429,0.0002715615,0.001221099,0.00003122229,0.05175217,0.00009753384,0.005659224,0.00006761529,0.0004368169,0.01207747],"study_design_scores_gemma":[0.2718446,0.0100589,0.6930553,0.002924464,0.002374772,7.962822e-7,0.01522724,0.00146359,0.002105042,0.00003373756,0.0002183801,0.0006931808],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914847,0.0002785438,0.0002231895,0.0005805341,0.0003125833,0.006474009,0.00001855384,0.00006591705,0.0005619618],"genre_scores_gemma":[0.9963509,0.00001311699,0.0008488683,0.001585442,0.0002284723,0.0007206381,0.0001078349,0.00006921424,0.00007546299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1989686,"threshold_uncertainty_score":0.9998847,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01709637035927511,"score_gpt":0.2633335422233731,"score_spread":0.246237171864098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}